Evidence map›Paper›PMID 23483520›Full record

ArticleJournal of neurovirology2013

Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Thep Chalermchai, Victor Valcour, Pasiri Sithinamsuwan, Suteeraporn Pinyakorn, David Clifford, Robert H Paul, Somporn Tipsuk, James L K Fletcher, Victor Degruttola, Silvia Ratto-Kim and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neurology and the Global HIV Epidemic.Seminars in neurology · 2014
    Review
  15. Article
  16. HIV-associated neurocognitive disorder.The Lancet. Infectious diseases · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Thep ChalermchaiSEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Victor Valcour
Pasiri Sithinamsuwan
Suteeraporn Pinyakorn
David Clifford
Robert H Paul
Somporn Tipsuk
James L K Fletcher
Victor Degruttola
Silvia Ratto-Kim
Nicholas Hutchings
Cecilia Shikuma
Jintanat Ananworanich
SEARCH 007 and 011 study groups
Thai Red Cross Society · THUniversity of California, San Francisco · USUniversity of Hawaiʻi at Mānoa · USWashington University in St. Louis · USHarvard University · USPhramongkutklao Hospital · TH

Funding

RESEARCH DESIGN AND BIOSTATISTICS COREU54MD007584 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI HEDGES, JERRIS ROBERT, MOKUAU, NOREEN · 2012 to 2018
$21.1M
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIVR01NS061696 · NINDS · UNIVERSITY OF HAWAII AT MANOA · PI VALCOUR, VICTOR · 2008 to 2012
$3.2M
HIV-1 Specific Immune Responses in Thai Individuals with HIV DementiaR01NS053359 · NINDS · UNIVERSITY OF HAWAII AT MANOA · PI KIM, SILVIA R · 2007 to 2011
$1.6M
NIMHD NIH HHS U54 MD007584NINDS NIH HHS R01 NS053359NINDS NIH HHS R01-NS053359NINDS NIH HHS R01 NS061696NINDS NIH HHS R01-NS061696
6 · The paper itself

Abstract

Although HIV-associated dementia (HAD) occurs in less than 5 % of individuals with access to combination antiretroviral therapy, rates of milder forms of HIV-associated neurocognitive disorder (HAND) are much higher. We sought to define an optimal cut point for the International HIV Dementia Scale (IHDS) in Thailand for the identification of symptomatic HAND, defined as both HAD and mild neurocognitive disorder. We then sought to determine if adding a simple test from a larger neuropsychological battery could improve the performance characteristics for identifying symptomatic HAND. In this study, subjects comprising 75 seropositive adults in Bangkok, Thailand, completed neuropsychological tests and underwent a full neurological assessment. HAND diagnoses were determined by consensus conference using the 2007 Frascati criteria, blinded to the IHDS results. The optimal IHDS cut point was determined by receiver operating characteristic analysis with cross-validation. Individual neuropsychological tests were then evaluated and combined with the IHDS to test performance characteristics. The IHDS was poor at detecting symptomatic HAND at the optimized cut point of ≤ 10 (sensitivity, 53.3 %; specificity, 89.8 %). Trail Making Test A was most effective in improving performance characteristics when combined with the IHDS, with net sensitivity of 86 % and specificity of 79 %. In this setting, the IHDS performed poorly in identifying symptomatic HAND, but was substantially improved by the addition of Trail Making Test A, which typically requires less than 2 min to complete. This combination should be validated in a larger setting since it may address the critical need for HAND screening instruments in international settings.

Indexed as

AdultAIDS Dementia ComplexCognitive DysfunctionFemaleHumansMaleResearch DesignROC CurveSeverity of Illness IndexThailandTrail Making Test

Identifiers

PMID23483520
PMCPMC3644005
OpenAlexW2059455019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.